Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela D'Angelo

Showing results (91-100 of 200) with videos related to

Pageof 20
Sort By:
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 8, 2012
Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Internal Medicine (Tokyo, Japan)|November 21, 2007
Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trialGiuseppe Derosa, Angela D'Angelo, Elena Fogari, et al.
Renal Failure|June 16, 2011
Treatment with calcimimetic (cinacalcet) alters epoetin dosage requirements in dialysis patients: preliminary reportMaria Fusaro, Angela D'Angelo, Agostino Naso, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 25, 2010
Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patientsGiuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, et al.
Journal of Clinical Lipidology|January 15, 2013
Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat loadGiuseppe Derosa, Arrigo F G Cicero, Elena Fogari, et al.
Inflammation|September 11, 2013
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Internal Medicine (Tokyo, Japan)|October 4, 2013
Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metforminGiuseppe Derosa, Anna Carbone, Angela D'Angelo, et al.
Journal of Clinical Medicine|April 27, 2024
Optic Nerve Neuroprotection in Glaucoma: A Narrative ReviewAngela D'Angelo, Livio Vitiello, Filippo Lixi, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 15, 2016
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patientsAlfredo Costa, Daniele Bosone, Matteo Cotta Ramusino, et al.
Journal of Hypertension|October 3, 2009
Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertensionLorenzo A Calò, Silvia Schiavo, Paul A Davis, et al.
Pageof 20

Showing results (91-100 of 200) with videos related to

Sort By:
Pageof 20
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 8, 2012
Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Internal Medicine (Tokyo, Japan)|November 21, 2007
Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trialGiuseppe Derosa, Angela D'Angelo, Elena Fogari, et al.
Renal Failure|June 16, 2011
Treatment with calcimimetic (cinacalcet) alters epoetin dosage requirements in dialysis patients: preliminary reportMaria Fusaro, Angela D'Angelo, Agostino Naso, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 25, 2010
Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patientsGiuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, et al.
Journal of Clinical Lipidology|January 15, 2013
Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat loadGiuseppe Derosa, Arrigo F G Cicero, Elena Fogari, et al.
Inflammation|September 11, 2013
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Internal Medicine (Tokyo, Japan)|October 4, 2013
Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metforminGiuseppe Derosa, Anna Carbone, Angela D'Angelo, et al.
Journal of Clinical Medicine|April 27, 2024
Optic Nerve Neuroprotection in Glaucoma: A Narrative ReviewAngela D'Angelo, Livio Vitiello, Filippo Lixi, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 15, 2016
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patientsAlfredo Costa, Daniele Bosone, Matteo Cotta Ramusino, et al.
Journal of Hypertension|October 3, 2009
Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertensionLorenzo A Calò, Silvia Schiavo, Paul A Davis, et al.
Pageof 20